In addition to syndromic diseases, PTCH1 mutations have been implicated in several cancers including sporadic basal cell carcinoma (BCC) [29], squamous cell carcinoma [30], medulloblastoma [8], and embryonal rhabdomyosarcoma [31]. The gene discussed is PTCH1; the disease is medulloblastoma.